Your browser doesn't support javascript.
loading
Management of Failing Kidney and Pancreas Transplantations.
Lubetzky, Michelle; Chauhan, Krutika; Alrata, Louai; Dubrawka, Casey; Abuazzam, Farah; Abdulkhalek, Samer; Abdulhadi, Tarek; Yaseen Alsabbagh, Dema; Singh, Neeraj; Lentine, Krista L; Tanriover, Bekir; Alhamad, Tarek.
Afiliación
  • Lubetzky M; Division of Nephrology, Department of Medicine, University of Texas in Austin, TX.
  • Chauhan K; Division of Nephrology, Department of Medicine, Washington University in St. Louis, MO.
  • Alrata L; Division of Nephrology, Department of Medicine, Washington University in St. Louis, MO.
  • Dubrawka C; Department of Pharmacy, Barnes Jewish Hospital, St. Louis, MO.
  • Abuazzam F; Division of Nephrology, Department of Medicine, Washington University in St. Louis, MO.
  • Abdulkhalek S; Division of Nephrology, Department of Medicine, Washington University in St. Louis, MO.
  • Abdulhadi T; Department of Medicine, Jamaica Hospital Medical Center, Queens, NY.
  • Yaseen Alsabbagh D; Division of Nephrology, Department of Medicine, Washington University in St. Louis, MO.
  • Singh N; Division of Nephrology, Department of Medicine, Louisiana State University in Shreveport, LA.
  • Lentine KL; Division of Nephrology, Department of Medicine, Saint Louis University, MO.
  • Tanriover B; Division of Nephrology, Department of Medicine, University of Arizona College of Medicine, AZ.
  • Alhamad T; Division of Nephrology, Department of Medicine, Washington University in St. Louis, MO. Electronic address: talhamad@wustl.edu.
Adv Kidney Dis Health ; 31(5): 476-482, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39232618
ABSTRACT
Survival rates for allografts have improved over the last 2 decades, yet failing allografts remains a challenge in the field of transplant. The risks of mortality and morbidity associated with failed allografts are compounded by infectious complications and metabolic abnormalities, emphasizing the need for a standardized approach to management. Management of failing allografts lacks consensus, highlighting the need for unified protocols to guide treatment protocols and minimize risks with postdialysis initiation. The decision to wean off immunosuppression depends on various factors, including living donor availability and infectious risks, necessitating improved coordination of care and a standard guideline. Treatment of failed pancreas focuses on glycemic control, with insulin as the mainstay, while considering surgical interventions such as graft pancreatectomy in advanced symptomatic cases. Navigating the complexities of failed allograft management demands a multidisciplinary approach and standardized stepwise protocol. Addressing the gaps in management plans for failing allografts and employing a systematic approach to transplant decisions will enhance patient outcomes and facilitate informed decision-making.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Trasplante de Páncreas Límite: Humans Idioma: En Revista: Adv Kidney Dis Health Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Trasplante de Páncreas Límite: Humans Idioma: En Revista: Adv Kidney Dis Health Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos